RDHL RDHL
Company Profile ↓Company Overview
RDHL (RDHL) is a publicly traded company listed on with a market capitalization of $34.12B. The valuation, growth and price-trend signals below summarize what matters most to investors and traders evaluating the stock.
Why Investors Should Care
Carries low leverage with a debt-to-equity ratio of 0.25.
Recent Developments
- 5-Year Trend Long-term compounding — revenue CAGR -83.3%.
Growth & Price Performance
Compounded Sales Growth
| 5 Years: | -83.34% |
| 1 Year: | - |
Stock Price Performance
| 1 Year: | -45.53% |
| 6 Months: | -40.18% |
| 3 Months: | -34.31% |
| 1 Month: | -8.97% |
Highlights auto-generated from reported financials and price data; not investment advice. Verify with official filings before acting.
- Price vs 50-DMABelow
- Price vs 200-DMABelow
- RSI (14)42.27 · Neutral
Auto-generated from price history and fundamentals; not investment advice.
Price Chart
Technical Trend
Computed from daily close history using EMA cross, slope, and RSI signals.
Note: intraday data is not stored locally. “Hourly” uses the most recent 10 daily candles as a short-term proxy.
Fundamental Growth Charts
No fundamental data available for this stock.
Interactive charts for Revenue, Net Income, EBITDA, Free Cash Flow, EPS, ROE, ROCE, Gross/Net/Operating Margin and more — switch metric and period using the dropdowns above. CAGR is computed across the displayed window (quarterly CAGR is annualised). Visual growth charts make it easy to spot multi-year compounding trends at a glance — far faster than reading raw numbers in a table.
PROS
No notable strengths flagged.
CONS
- Revenue declined at -83.3% CAGR over 5 years.
- Trading 73.4% below its 52-week high.
- In a downtrend (50-DMA below 200-DMA).
* The pros and cons are auto-generated from financial metrics.
Valuation
Growth (CAGR)
Profitability & Returns
Balance Sheet & Liquidity
Ownership
Financial Snapshot
Financial Statements Quarterly Results · Profit & Loss · Balance Sheet · Cash Flows · Ratios
Profit & Loss (Annual)
Figures in USD.
| Metric | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|
| Revenue | - | 61.80M | 0 | 0 | 286.00K |
| Cost of Revenue | 49.41M | 33.34M | 3.46M | 3.19M | - |
| Gross Profit | 36.35M | 28.46M | 3.07M | 4.85M | - |
| Operating Expenses | - | 71.31M | 9.55M | 6.47M | 8.20M |
| Operating Income | - | -42.84M | -9.55M | -6.47M | -7.91M |
| EBITDA | - | -22.18M | -16.44M | 1.02M | -7.65M |
| Interest Expense | - | 41.33M | 63.00K | 44.00K | 19.00K |
| Pretax Income | - | -71.67M | -18.50M | 360.00K | -8.08M |
| Tax Provision | - | - | - | - | - |
| Net Income | - | -71.67M | 23.92M | -8.27M | -429.00K |
| Diluted EPS | -2,100.00 | -1,200.00 | 100.00 | 0.00 | - |
Balance Sheet (Annual)
Figures in USD.
| Metric | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|
| Total Assets | - | 158.87M | 23.05M | 18.04M | 25.34M |
| Current Assets | - | 85.90M | 16.14M | 11.91M | 6.53M |
| Cash & Equivalents | - | 19.97M | 5.57M | 4.62M | 3.97M |
| Inventory | - | 11.01M | 4.39M | 3.65M | 0 |
| Receivables | - | 34.52M | 2.59M | 2.54M | 79.00K |
| Total Liabilities | - | 207.27M | 20.98M | 22.73M | 21.08M |
| Current Liabilities | - | 197.45M | 19.98M | 22.22M | 19.22M |
| Long Term Debt | 83.62M | - | - | - | - |
| Total Debt | - | 122.69M | 1.17M | 356.00K | 1.07M |
| Total Equity | - | -48.40M | 2.07M | -4.68M | 4.27M |
| Shares Outstanding | - | 931.96M | 7.87B | 12.90B | 50.92B |
Cash Flows (Annual)
Figures in USD.
| Metric | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|
| Operating Cash Flow | - | -29.18M | -35.82M | -9.37M | -9.65M |
| Investing Cash Flow | - | 8.30M | 4.00K | -9.00K | 1.69M |
| Financing Cash Flow | - | 11.45M | 21.44M | 8.42M | 7.32M |
| Capital Expenditure | - | -198.00K | -11.00K | -9.00K | -5.00K |
| Free Cash Flow | - | -29.38M | -35.83M | -9.38M | -9.66M |
| Net Change in Cash | - | -9.43M | -14.38M | -961.00K | -644.00K |
Ratios (Annual)
Figures in %.
| Metric | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|
| Gross Margin % | - | 46.1% | - | - | - |
| Operating Margin % | - | -69.3% | - | - | -2,765.4% |
| Net Margin % | - | -116.0% | - | - | -150.0% |
| ROE % | - | 148.1% | 1,155.9% | 176.6% | -10.1% |
| ROCE % | - | 111.0% | -311.6% | 154.9% | -129.1% |
Shareholding Pattern
Analyst View
Analyst aggregate. Targets and ratings update periodically; not investment advice.
Latest News
Recent headlines for RDHL
Ebola outbreak: 1,407 deaths as opaganib discussions continue - Stock Titan
<a href="https://news.google.com/rss/articles/CBMivAFBVV95cUxNMi1Zczd2SGRGQkxtd195S2w4QWJ0NVBYOWFCTHBTNDZTV0pZX1E3UWFMN3U2b3RxWmZMZFBmdkhuVmpNa2pYQjU3RXVkQ01sYnhwdWZBX0tNU0F3d3dMSjBETHA4ZjFUVm1HUU5nMS1mbGFVekR6THR3bzhLeGRkbFhIMHBlZENtcmFwTC…
Redhill Biopharma Ltd. Revenue Breakdown – NASDAQ:RDHL - TradingView
<a href="https://news.google.com/rss/articles/CBMid0FVX3lxTFBoNGtfMzhjelVGSk8xSHJ2SXcxa0xCYVBCVlJpLWVVS1BKX2lLUEhXR1psOUZGcVFkc19KdG5FTFI0WEl3X1FmSXhNMHI3U0tJdXpCLXhka3gzWHlOR3FDSmlITlBIcW1QZVRSYXNVMDZsRVJoWS1n?oc=5" target="_blank">Redhill…
RDHL|Redhill Biopharma Ltd|Price:0.657|Chg%:+0.007 - TradingKey
<a href="https://news.google.com/rss/articles/CBMibkFVX3lxTE5oREhPX1NtY3VNTDkxZ3p4NENiaWNpd1lLLUxXbTZwVmpsbDY0NmNQeTZ6WVhySHJNbl9MR3FHdkotNlI4cXhIbEY2a25TSVJjYThNOC1JTUpKNURjclB2bm1nOWNUR3dnMVJVcThB?oc=5" target="_blank">RDHL|Redhill Biopha…
Redhill Biopharma stock soars on GLP-1 side effect treatment progress - Investing.com
<a href="https://news.google.com/rss/articles/CBMiygFBVV95cUxQUHl6anU4c0ZZN3FwZThtWURlT1h5ajI1am44c0NxOFpZbWRrRUVCelU4dGQ5Q0lvd1p6UkFkVlpQRkJwXzFvU3U0RWxRcG5QVVBtUnJuR25wMHRZS1g3V0dVWDhvenV2TURpdlFtamh4RzRuQ2xfekxMaXBudUExcjhvbnhnQ0t2N3hxMn…
RDHL Should I Buy - Intellectia AI
<a href="https://news.google.com/rss/articles/CBMiXkFVX3lxTE1xSmtTZFRLLUp0TnFlazU3UTNGbEczcldwY19uNmtCX19XaXFpdWVzWmFXMmVKck1NQnFSVnZZR2tvWEJWMGtiYml1VGdHUDEzX0VLNDZHVDV5RVFJU2c?oc=5" target="_blank">RDHL Should I Buy</a> <font c…
RedHill Biopharma Announces Closing of Up To $19.4 Million Private Placement - PR Newswire
<a href="https://news.google.com/rss/articles/CBMiywFBVV95cUxPMzdqbUhUWno4UGZveXJDbm1HOURmX2ZyTUJqMFRqNW5PSkNfU0tmNXdxT3hFZ1Z0SlhJZUNLcHYzdFFjNmVzSlZWMzdJMFNRTXg1V0dBY1hJRjdvQmx2ZU1ScTlxMm4ydGg1LWNUVVEwMTA4TFU1TWI4am5yWXlOLURKS2NSTlYxREJ0Nl…
RDHL — Frequently Asked Questions
What is the current share price of RDHL?
As of 2026-08-05 17:25 PDT, RDHL trades at $0.67 on NASDAQ/NYSE. Its 52-week range is $0.63 to $2.52.
What is the market capitalisation of RDHL?
RDHL has a market capitalisation of $34.12B on NASDAQ/NYSE.
What is the return on equity (ROE) of RDHL?
RDHL has a return on equity (ROE) of -10.05%. Its return on capital employed (ROCE) is -129.15%.
Is RDHL a good stock to buy?
This page provides a data-driven analysis of RDHL, including valuation ratios, profitability, growth trends, auto-generated pros and cons, peer comparison and AI exposure. Review these fundamentals alongside your own research and risk tolerance. This is informational content, not investment advice.